Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration
![]() |
MELBOURNE, Australia and PALO ALTO, Calif., Dec. 11, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces a strategic clinical collaboration with Varian, a Siemens Healthineers company and global leader in radiation oncology, to develop novel clinical applications that combine Telix's theranostic...
Read more: Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration





